
Global Pharmaceutical Excipients Market Growth 2022-2028
Description
The global Pharmaceutical Excipients market size is predicted to grow from US$ 46800 million in 2025 to US$ 63880 million in 2031; it is expected to grow at a CAGR of 5.3% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Pharmaceutical excipients are substances that are included in a pharmaceutical dosage form not for their direct therapeutic action, but to aid the manufacturing process, to protect, support or enhance stability, or for bioavailability or patient acceptability.
Global Pharmaceutical Excipients key players include Hnerkang、DowDuPont (FMC)、JRS Pharma、BASF、Lubrizol、Ashland、Croda International、Roquette、Shin-Etsu、Evonik, etc. Global top ten manufacturers hold a share about 7%. North America is the largest market, with a share about 35%, followed by Europe and Asia Pacific, have a share over 60 percent.
With the continuous progress and innovation of the pharmaceutical industry, the market demand for pharmaceutical excipients is also growing. Especially in the context of the improvement of global health awareness, the intensification of an aging society, and the increasing demand for efficient and safe drugs, the application scenarios of pharmaceutical excipients are becoming more and more extensive, and the market demand is expanding.
With the rise of new treatment methods such as biopharmaceuticals, personalized drugs, and targeted therapy, higher requirements are placed on the functions and performance of pharmaceutical excipients. For example, biologics and targeted drugs require specific excipients to improve the stability of drugs, improve the efficacy, or prolong the release time of drugs. In addition, the improvement of regulations and the improvement of industry standards have also promoted the standardized development of the pharmaceutical excipients market. In some regions, the government's supervision of drug quality has become more stringent, prompting pharmaceutical companies to pay more attention to quality and safety in the selection of pharmaceutical excipients, thereby promoting the demand for high-performance excipients.
LP Information, Inc. (LPI) ' newest research report, the “Pharmaceutical Excipients Industry Forecast” looks at past sales and reviews total world Pharmaceutical Excipients sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Excipients sales for 2025 through 2031. With Pharmaceutical Excipients sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Excipients industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical Excipients landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Excipients portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Excipients market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Excipients and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Excipients.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Excipients market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Starch and Derivatives
Sucrose
Cellulose and Derivatives
Dextrose
Polyols
Inorganic Salts
Others
Segmentation by Application:
Oral Formulations
Topical Formulations
Parenteral Formulations
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
DowDuPont (FMC)
JRS Pharma
BASF
Lubrizol
Ashland
Croda International
Roquette
Shin-Etsu
Evonik
Associated British Foods
Südzucker AG
Mitsubishi
Hunan ER-KANG
Anhui Sunhere
Tianjin Chase Sun
Xiwang Group
ShengTai Group
Nanjing Well Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pharmaceutical Excipients market?
What factors are driving Pharmaceutical Excipients market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pharmaceutical Excipients market opportunities vary by end market size?
How does Pharmaceutical Excipients break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Pharmaceutical excipients are substances that are included in a pharmaceutical dosage form not for their direct therapeutic action, but to aid the manufacturing process, to protect, support or enhance stability, or for bioavailability or patient acceptability.
Global Pharmaceutical Excipients key players include Hnerkang、DowDuPont (FMC)、JRS Pharma、BASF、Lubrizol、Ashland、Croda International、Roquette、Shin-Etsu、Evonik, etc. Global top ten manufacturers hold a share about 7%. North America is the largest market, with a share about 35%, followed by Europe and Asia Pacific, have a share over 60 percent.
With the continuous progress and innovation of the pharmaceutical industry, the market demand for pharmaceutical excipients is also growing. Especially in the context of the improvement of global health awareness, the intensification of an aging society, and the increasing demand for efficient and safe drugs, the application scenarios of pharmaceutical excipients are becoming more and more extensive, and the market demand is expanding.
With the rise of new treatment methods such as biopharmaceuticals, personalized drugs, and targeted therapy, higher requirements are placed on the functions and performance of pharmaceutical excipients. For example, biologics and targeted drugs require specific excipients to improve the stability of drugs, improve the efficacy, or prolong the release time of drugs. In addition, the improvement of regulations and the improvement of industry standards have also promoted the standardized development of the pharmaceutical excipients market. In some regions, the government's supervision of drug quality has become more stringent, prompting pharmaceutical companies to pay more attention to quality and safety in the selection of pharmaceutical excipients, thereby promoting the demand for high-performance excipients.
LP Information, Inc. (LPI) ' newest research report, the “Pharmaceutical Excipients Industry Forecast” looks at past sales and reviews total world Pharmaceutical Excipients sales in 2024, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Excipients sales for 2025 through 2031. With Pharmaceutical Excipients sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Excipients industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical Excipients landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Excipients portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Excipients market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Excipients and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Excipients.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Excipients market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Starch and Derivatives
Sucrose
Cellulose and Derivatives
Dextrose
Polyols
Inorganic Salts
Others
Segmentation by Application:
Oral Formulations
Topical Formulations
Parenteral Formulations
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
DowDuPont (FMC)
JRS Pharma
BASF
Lubrizol
Ashland
Croda International
Roquette
Shin-Etsu
Evonik
Associated British Foods
Südzucker AG
Mitsubishi
Hunan ER-KANG
Anhui Sunhere
Tianjin Chase Sun
Xiwang Group
ShengTai Group
Nanjing Well Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Pharmaceutical Excipients market?
What factors are driving Pharmaceutical Excipients market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pharmaceutical Excipients market opportunities vary by end market size?
How does Pharmaceutical Excipients break out by Type, by Application?
Table of Contents
120 Pages
- 1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
- 1.8 Market Estimation Caveats
- 2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Pharmaceutical Excipients Annual Sales 2020-
- 2.1.2 World Current & Future Analysis for Pharmaceutical Excipients by Geographic Region, 2020, 2024 &
- 2.1.3 World Current & Future Analysis for Pharmaceutical Excipients by Country/Region, 2020, 2024 &
- 2.2 Pharmaceutical Excipients Segment by Type
- 2.2.1 Starch and Derivatives
- 2.2.2 Sucrose
- 2.2.3 Cellulose and Derivatives
- 2.2.4 Dextrose
- 2.2.5 Polyols
- 2.2.6 Inorganic Salts
- 2.2.7 Others
- 2.3 Pharmaceutical Excipients Sales by Type
- 2.3.1 Global Pharmaceutical Excipients Sales Market Share by Type (2020-2025)
- 2.3.2 Global Pharmaceutical Excipients Revenue and Market Share by Type (2020-2025)
- 2.3.3 Global Pharmaceutical Excipients Sale Price by Type (2020-2025)
- 2.4 Pharmaceutical Excipients Segment by Application
- 2.4.1 Oral Formulations
- 2.4.2 Topical Formulations
- 2.4.3 Parenteral Formulations
- 2.4.4 Other
- 2.5 Pharmaceutical Excipients Sales by Application
- 2.5.1 Global Pharmaceutical Excipients Sale Market Share by Application (2020-2025)
- 2.5.2 Global Pharmaceutical Excipients Revenue and Market Share by Application (2020-2025)
- 2.5.3 Global Pharmaceutical Excipients Sale Price by Application (2020-2025)
- 3 Global by Company
- 3.1 Global Pharmaceutical Excipients Breakdown Data by Company
- 3.1.1 Global Pharmaceutical Excipients Annual Sales by Company (2020-2025)
- 3.1.2 Global Pharmaceutical Excipients Sales Market Share by Company (2020-2025)
- 3.2 Global Pharmaceutical Excipients Annual Revenue by Company (2020-2025)
- 3.2.1 Global Pharmaceutical Excipients Revenue by Company (2020-2025)
- 3.2.2 Global Pharmaceutical Excipients Revenue Market Share by Company (2020-2025)
- 3.3 Global Pharmaceutical Excipients Sale Price by Company
- 3.4 Key Manufacturers Pharmaceutical Excipients Producing Area Distribution, Sales Area, Product Type
- 3.4.1 Key Manufacturers Pharmaceutical Excipients Product Location Distribution
- 3.4.2 Players Pharmaceutical Excipients Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
- 3.6 New Products and Potential Entrants
- 3.7 Market M&A Activity & Strategy
- 4 World Historic Review for Pharmaceutical Excipients by Geographic Region
- 4.1 World Historic Pharmaceutical Excipients Market Size by Geographic Region (2020-2025)
- 4.1.1 Global Pharmaceutical Excipients Annual Sales by Geographic Region (2020-2025)
- 4.1.2 Global Pharmaceutical Excipients Annual Revenue by Geographic Region (2020-2025)
- 4.2 World Historic Pharmaceutical Excipients Market Size by Country/Region (2020-2025)
- 4.2.1 Global Pharmaceutical Excipients Annual Sales by Country/Region (2020-2025)
- 4.2.2 Global Pharmaceutical Excipients Annual Revenue by Country/Region (2020-2025)
- 4.3 Americas Pharmaceutical Excipients Sales Growth
- 4.4 APAC Pharmaceutical Excipients Sales Growth
- 4.5 Europe Pharmaceutical Excipients Sales Growth
- 4.6 Middle East & Africa Pharmaceutical Excipients Sales Growth
- 5 Americas
- 5.1 Americas Pharmaceutical Excipients Sales by Country
- 5.1.1 Americas Pharmaceutical Excipients Sales by Country (2020-2025)
- 5.1.2 Americas Pharmaceutical Excipients Revenue by Country (2020-2025)
- 5.2 Americas Pharmaceutical Excipients Sales by Type (2020-2025)
- 5.3 Americas Pharmaceutical Excipients Sales by Application (2020-2025)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
- 6 APAC
- 6.1 APAC Pharmaceutical Excipients Sales by Region
- 6.1.1 APAC Pharmaceutical Excipients Sales by Region (2020-2025)
- 6.1.2 APAC Pharmaceutical Excipients Revenue by Region (2020-2025)
- 6.2 APAC Pharmaceutical Excipients Sales by Type (2020-2025)
- 6.3 APAC Pharmaceutical Excipients Sales by Application (2020-2025)
- 6.4 China
- 6.5 Japan
- 6.6 South Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 China Taiwan
- 7 Europe
- 7.1 Europe Pharmaceutical Excipients by Country
- 7.1.1 Europe Pharmaceutical Excipients Sales by Country (2020-2025)
- 7.1.2 Europe Pharmaceutical Excipients Revenue by Country (2020-2025)
- 7.2 Europe Pharmaceutical Excipients Sales by Type (2020-2025)
- 7.3 Europe Pharmaceutical Excipients Sales by Application (2020-2025)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 8 Middle East & Africa
- 8.1 Middle East & Africa Pharmaceutical Excipients by Country
- 8.1.1 Middle East & Africa Pharmaceutical Excipients Sales by Country (2020-2025)
- 8.1.2 Middle East & Africa Pharmaceutical Excipients Revenue by Country (2020-2025)
- 8.2 Middle East & Africa Pharmaceutical Excipients Sales by Type (2020-2025)
- 8.3 Middle East & Africa Pharmaceutical Excipients Sales by Application (2020-2025)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
- 9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
- 10 Manufacturing Cost Structure Analysis
- 10.1 Raw Material and Suppliers
- 10.2 Manufacturing Cost Structure Analysis of Pharmaceutical Excipients
- 10.3 Manufacturing Process Analysis of Pharmaceutical Excipients
- 10.4 Industry Chain Structure of Pharmaceutical Excipients
- 11 Marketing, Distributors and Customer
- 11.1 Sales Channel
- 11.1.1 Direct Channels
- 11.1.2 Indirect Channels
- 11.2 Pharmaceutical Excipients Distributors
- 11.3 Pharmaceutical Excipients Customer
- 12 World Forecast Review for Pharmaceutical Excipients by Geographic Region
- 12.1 Global Pharmaceutical Excipients Market Size Forecast by Region
- 12.1.1 Global Pharmaceutical Excipients Forecast by Region (2026-2031)
- 12.1.2 Global Pharmaceutical Excipients Annual Revenue Forecast by Region (2026-2031)
- 12.2 Americas Forecast by Country (2026-2031)
- 12.3 APAC Forecast by Region (2026-2031)
- 12.4 Europe Forecast by Country (2026-2031)
- 12.5 Middle East & Africa Forecast by Country (2026-2031)
- 12.6 Global Pharmaceutical Excipients Forecast by Type (2026-2031)
- 12.7 Global Pharmaceutical Excipients Forecast by Application (2026-2031)
- 13 Key Players Analysis
- 13.1 DowDuPont (FMC)
- 13.1.1 DowDuPont (FMC) Company Information
- 13.1.2 DowDuPont (FMC) Pharmaceutical Excipients Product Portfolios and Specifications
- 13.1.3 DowDuPont (FMC) Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
- 13.1.4 DowDuPont (FMC) Main Business Overview
- 13.1.5 DowDuPont (FMC) Latest Developments
- 13.2 JRS Pharma
- 13.2.1 JRS Pharma Company Information
- 13.2.2 JRS Pharma Pharmaceutical Excipients Product Portfolios and Specifications
- 13.2.3 JRS Pharma Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
- 13.2.4 JRS Pharma Main Business Overview
- 13.2.5 JRS Pharma Latest Developments
- 13.3 BASF
- 13.3.1 BASF Company Information
- 13.3.2 BASF Pharmaceutical Excipients Product Portfolios and Specifications
- 13.3.3 BASF Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
- 13.3.4 BASF Main Business Overview
- 13.3.5 BASF Latest Developments
- 13.4 Lubrizol
- 13.4.1 Lubrizol Company Information
- 13.4.2 Lubrizol Pharmaceutical Excipients Product Portfolios and Specifications
- 13.4.3 Lubrizol Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
- 13.4.4 Lubrizol Main Business Overview
- 13.4.5 Lubrizol Latest Developments
- 13.5 Ashland
- 13.5.1 Ashland Company Information
- 13.5.2 Ashland Pharmaceutical Excipients Product Portfolios and Specifications
- 13.5.3 Ashland Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
- 13.5.4 Ashland Main Business Overview
- 13.5.5 Ashland Latest Developments
- 13.6 Croda International
- 13.6.1 Croda International Company Information
- 13.6.2 Croda International Pharmaceutical Excipients Product Portfolios and Specifications
- 13.6.3 Croda International Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
- 13.6.4 Croda International Main Business Overview
- 13.6.5 Croda International Latest Developments
- 13.7 Roquette
- 13.7.1 Roquette Company Information
- 13.7.2 Roquette Pharmaceutical Excipients Product Portfolios and Specifications
- 13.7.3 Roquette Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
- 13.7.4 Roquette Main Business Overview
- 13.7.5 Roquette Latest Developments
- 13.8 Shin-Etsu
- 13.8.1 Shin-Etsu Company Information
- 13.8.2 Shin-Etsu Pharmaceutical Excipients Product Portfolios and Specifications
- 13.8.3 Shin-Etsu Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
- 13.8.4 Shin-Etsu Main Business Overview
- 13.8.5 Shin-Etsu Latest Developments
- 13.9 Evonik
- 13.9.1 Evonik Company Information
- 13.9.2 Evonik Pharmaceutical Excipients Product Portfolios and Specifications
- 13.9.3 Evonik Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
- 13.9.4 Evonik Main Business Overview
- 13.9.5 Evonik Latest Developments
- 13.10 Associated British Foods
- 13.10.1 Associated British Foods Company Information
- 13.10.2 Associated British Foods Pharmaceutical Excipients Product Portfolios and Specifications
- 13.10.3 Associated British Foods Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
- 13.10.4 Associated British Foods Main Business Overview
- 13.10.5 Associated British Foods Latest Developments
- 13.11 Südzucker AG
- 13.11.1 Südzucker AG Company Information
- 13.11.2 Südzucker AG Pharmaceutical Excipients Product Portfolios and Specifications
- 13.11.3 Südzucker AG Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
- 13.11.4 Südzucker AG Main Business Overview
- 13.11.5 Südzucker AG Latest Developments
- 13.12 Mitsubishi
- 13.12.1 Mitsubishi Company Information
- 13.12.2 Mitsubishi Pharmaceutical Excipients Product Portfolios and Specifications
- 13.12.3 Mitsubishi Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
- 13.12.4 Mitsubishi Main Business Overview
- 13.12.5 Mitsubishi Latest Developments
- 13.13 Hunan ER-KANG
- 13.13.1 Hunan ER-KANG Company Information
- 13.13.2 Hunan ER-KANG Pharmaceutical Excipients Product Portfolios and Specifications
- 13.13.3 Hunan ER-KANG Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
- 13.13.4 Hunan ER-KANG Main Business Overview
- 13.13.5 Hunan ER-KANG Latest Developments
- 13.14 Anhui Sunhere
- 13.14.1 Anhui Sunhere Company Information
- 13.14.2 Anhui Sunhere Pharmaceutical Excipients Product Portfolios and Specifications
- 13.14.3 Anhui Sunhere Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
- 13.14.4 Anhui Sunhere Main Business Overview
- 13.14.5 Anhui Sunhere Latest Developments
- 13.15 Tianjin Chase Sun
- 13.15.1 Tianjin Chase Sun Company Information
- 13.15.2 Tianjin Chase Sun Pharmaceutical Excipients Product Portfolios and Specifications
- 13.15.3 Tianjin Chase Sun Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
- 13.15.4 Tianjin Chase Sun Main Business Overview
- 13.15.5 Tianjin Chase Sun Latest Developments
- 13.16 Xiwang Group
- 13.16.1 Xiwang Group Company Information
- 13.16.2 Xiwang Group Pharmaceutical Excipients Product Portfolios and Specifications
- 13.16.3 Xiwang Group Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
- 13.16.4 Xiwang Group Main Business Overview
- 13.16.5 Xiwang Group Latest Developments
- 13.17 ShengTai Group
- 13.17.1 ShengTai Group Company Information
- 13.17.2 ShengTai Group Pharmaceutical Excipients Product Portfolios and Specifications
- 13.17.3 ShengTai Group Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
- 13.17.4 ShengTai Group Main Business Overview
- 13.17.5 ShengTai Group Latest Developments
- 13.18 Nanjing Well Pharmaceutical
- 13.18.1 Nanjing Well Pharmaceutical Company Information
- 13.18.2 Nanjing Well Pharmaceutical Pharmaceutical Excipients Product Portfolios and Specifications
- 13.18.3 Nanjing Well Pharmaceutical Pharmaceutical Excipients Sales, Revenue, Price and Gross Margin (2020-2025)
- 13.18.4 Nanjing Well Pharmaceutical Main Business Overview
- 13.18.5 Nanjing Well Pharmaceutical Latest Developments
- 14 Research Findings and Conclusion
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.